Treatment Outcome: Clinical Trials

4 trials for Treatment Outcome, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 recruiting, 1 unknown. 4 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 34Completed 2, Recruiting 1, Unknown 1

Follow Treatment Outcome: new trials by email Literature Review of Treatment Outcome trials Research Report on Treatment Outcome

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Early Versus Late Initiation of Edaravone Dexborneol on Neural Function in Patients With Acute Ischemic Stroke
Edaravone Dexborneol Concentrated Solution for injection, Edaravone Dexborneol placebo - Ischemic Stroke, Acute, Treatment Outcome
Phase 3UnknownXiangya Hospital of Central South University2122023-07-012023-06-27
Multicenter Clinical Trial on the Effectiveness and Safety of Instillation of BCG and Alternative BCG Protocols for Intermediate and High-risk Non-muscle Invasive Bladder Cancer
Tislelizumab in Combination with Bacillus Calmette-Guérin - Urinary Bladder Neoplasms, BCG Vaccine
Phase 3RecruitingFujian Medical University Union Hospital762023-06-012024-06-04
Efficacy and Safety of a Solution for Endoscopic Mucosal Resection of Colonic Lesions
Mucopolysaccharide saline solution 0.9%, Saline solution 0.9% - Endoscopic Mucosal Resection, Colonic Neoplasms
Phase 3CompletedNakafarma S.L.522021-01-182025-04-09
Vortioxetine (Lu AA21004) 10 and 20 mg for Treatment of Major Depressive Disorder With Sexual Dysfunction
Vortioxetine, Escitalopram, Placebo - Treatment Outcome
Phase 3CompletedTakeda4472011-06-012014-10-09

Narrower conditions

Colonic Neoplasms (1)  ·  Depression (1)  ·  Depressive Disorder, Major (1)  ·  Ischemic Stroke (1)  ·  Motor Activity (1)  ·  Neoplasm Recurrence, Local (1)  ·  Sexual Dysfunction, Physiological (1)  ·  Urinary Bladder Neoplasms (1)

Broader conditions

Behavior (2)  ·  Neoplasms (2)  ·  Neoplasms by Site (2)  ·  Urogenital Diseases (2)  ·  Behavioral Symptoms (1)  ·  Brain Diseases (1)  ·  Cardiovascular Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Cerebrovascular Disorders (1)  ·  Colonic Diseases (1)  ·  Colorectal Neoplasms (1)  ·  Depressive Disorder (1)  ·  Digestive System Diseases (1)  ·  Digestive System Neoplasms (1)  ·  Female Urogenital Diseases (1)

Interventions

Escitalopram (1)  ·  Injections (1)  ·  Saline Solution (1)  ·  Vortioxetine (1)  ·  tislelizumab (1)

Sponsors

Fujian Medical University Union Hospital (1)  ·  Nakafarma S.L. (1)  ·  Takeda (1)  ·  Xiangya Hospital of Central South University (1)

Countries

China (2)  ·  Canada (1)  ·  Spain (1)  ·  United States (1)

Top investigators

Jose Antonio Morales Molina, PhD in Pharmacy (1)  ·  Zhang Le, PhD (1)  ·  Zhenlin Chen (1)

Results publications

PMID 31010445, PMID 33588596, PMID 34487721